ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

KROS Keros Therapeutics Inc

60.57
3.47 (6.08%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Keros Therapeutics Inc KROS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
3.47 6.08% 60.57 10:00:00
Open Price Low Price High Price Close Price Previous Close
57.32 57.32 62.19 60.57 57.10
more quote information »

Recent News

Date Time Source Heading
14/3/202423:00GLOBEKeros Therapeutics Announces U.S. FDA Fast Track Designation..
07/3/202400:01EDGAR2Form 8-K - Current report
06/3/202400:02EDGAR2Form 8-K - Current report
06/3/202400:01EDGAR2Form 8-K - Current report
06/3/202400:00GLOBEKeros Therapeutics to Present at Leerink Partners 2024..
29/2/202408:02EDGAR2Form 8-K - Current report
29/2/202408:01GLOBEKeros Therapeutics Reports Recent Business Highlights and..
24/2/202409:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202412:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202412:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202412:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202412:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202400:00GLOBEKeros Therapeutics To Present at Pulmonary Vascular Research..
10/1/202400:01EDGAR2Form 8-K - Current report
10/1/202400:00GLOBEKeros Therapeutics Announces Closing of Upsized Public..
09/1/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:04EDGAR2Form 8-K - Current report
05/1/202408:04EDGAR2Form 144 - Report of proposed sale of securities
05/1/202408:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/1/202413:29GLOBEKeros Therapeutics Announces Pricing of Upsized Public..
04/1/202408:05GLOBEKeros Therapeutics Announces Proposed Public Offering of..
04/1/202408:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/1/202400:04EDGAR2Form 8-K - Current report
11/12/202322:02EDGAR2Form 8-K - Current report
11/12/202322:00GLOBEKeros Therapeutics Presents Clinical Data from its KER-050..
08/11/202300:01EDGAR2Form 8-K - Current report
08/11/202300:00GLOBEKeros Therapeutics to Present at Upcoming Healthcare..
07/11/202300:11EDGAR2Form 8-K - Current report
07/11/202300:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202300:01EDGAR2Form 8-K - Current report
07/11/202300:00GLOBEKeros Therapeutics Reports Recent Business Highlights and..
03/11/202300:00GLOBEKeros Therapeutics to Present at the 65th American Society..
04/10/202323:01EDGAR2Form 8-K - Current report
04/10/202323:00GLOBEKeros Therapeutics Presents Preclinical Data from its..
05/9/202322:02EDGAR2Form 8-K - Current report
05/9/202322:00GLOBEKeros Therapeutics to Present at Upcoming Healthcare..
08/8/202306:02EDGAR2Form 8-K - Current report
07/8/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202322:00EDGAR2Form 8-K - Current report
07/8/202322:00GLOBEKeros Therapeutics Reports Recent Business Highlights and..
28/7/202306:01GLOBECorrected: Keros Therapeutics to Host Conference Call and..
24/7/202322:01EDGAR2Form 8-K - Current report
24/7/202322:00GLOBEKeros Therapeutics to Host Conference Call and Webcast to..
12/6/202322:00GLOBEKeros Therapeutics Announces Update to Participation at the..
09/6/202320:00GLOBEKeros Therapeutics Presents Clinical Trial and Preclinical..
07/6/202322:00GLOBEKeros Therapeutics to Present at Goldman Sach’s 44th Annual..
22/5/202323:00GLOBEKeros Therapeutics Presents Preclinical and Clinical Data..
12/5/202306:01GLOBEKeros Therapeutics to Present at the 28th Annual Congress of..

Your Recent History

Delayed Upgrade Clock